Gregory L Weaver is Chief Financial Officer of ATAI Life Sciences N.V.. Currently has a direct ownership of 4,666 shares of ATAI, which is worth approximately $5,552. The most recent transaction as insider was on Jun 22, 2021, when has been sold 4,666 shares (Common Shares) at a price of $15.0 per share, resulting in proceeds of $69,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.67K
0% 3M change
0% 12M change
Total Value Held $5,552

GREGORY L WEAVER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2021
BUY
Open market or private purchase
$69,990 $15.0 p/Share
4,666 Added 50.0%
4,666 Common Shares

Also insider at

ATOS
ATOSSA THERAPEUTICS, INC. Healthcare
ALT
Altimmune, Inc. Healthcare
GLW

Gregory L Weaver

Chief Financial Officer
Berlin, 2M

Track Institutional and Insider Activities on ATAI

Follow ATAI Life Sciences N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATAI shares.

Notify only if

Insider Trading

Get notified when an Atai Life Sciences N.V. insider buys or sells ATAI shares.

Notify only if

News

Receive news related to ATAI Life Sciences N.V.

Track Activities on ATAI